Mine Eray

776 total citations
29 papers, 645 citations indexed

About

Mine Eray is a scholar working on Immunology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Mine Eray has authored 29 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 13 papers in Molecular Biology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Mine Eray's work include Cell death mechanisms and regulation (11 papers), Lymphoma Diagnosis and Treatment (9 papers) and Immunotherapy and Immune Responses (7 papers). Mine Eray is often cited by papers focused on Cell death mechanisms and regulation (11 papers), Lymphoma Diagnosis and Treatment (9 papers) and Immunotherapy and Immune Responses (7 papers). Mine Eray collaborates with scholars based in Finland, Sweden and Germany. Mine Eray's co-authors include Jukka Pelkonen, Mikko Mättö, Joanna Skommer, Donald Włodkowic, Antti Ropponen, Matti Kaartinen, Leif C. Andersson, Riikka Pellinen, Jarmo Wahlfors and Tuula Lehtinen and has published in prestigious journals such as European Journal of Immunology, Experimental Cell Research and Carcinogenesis.

In The Last Decade

Mine Eray

28 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mine Eray Finland 13 247 181 163 111 102 29 645
Masayuki Asano Japan 16 331 1.3× 306 1.7× 243 1.5× 50 0.5× 169 1.7× 36 1.1k
Babette Aicher Germany 11 423 1.7× 140 0.8× 79 0.5× 41 0.4× 105 1.0× 28 607
Prahlad V. Raninga Australia 15 533 2.2× 71 0.4× 78 0.5× 44 0.4× 175 1.7× 25 742
Mikko Mättö Finland 11 206 0.8× 171 0.9× 90 0.6× 33 0.3× 44 0.4× 16 470
Shilpak Chatterjee United States 18 254 1.0× 61 0.3× 415 2.5× 92 0.8× 307 3.0× 40 947
Roseanne S. Wexler United States 7 273 1.1× 56 0.3× 63 0.4× 17 0.2× 84 0.8× 11 599
Isabel Serrano Spain 11 589 2.4× 155 0.9× 87 0.5× 15 0.1× 130 1.3× 14 856
Mohini Singh Canada 13 347 1.4× 86 0.5× 53 0.3× 40 0.4× 267 2.6× 34 755
Carla Vetrugno Italy 16 251 1.0× 84 0.5× 74 0.5× 32 0.3× 243 2.4× 29 605
Ahmed F. Salem United States 21 799 3.2× 186 1.0× 44 0.3× 56 0.5× 249 2.4× 42 1.2k

Countries citing papers authored by Mine Eray

Since Specialization
Citations

This map shows the geographic impact of Mine Eray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mine Eray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mine Eray more than expected).

Fields of papers citing papers by Mine Eray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mine Eray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mine Eray. The network helps show where Mine Eray may publish in the future.

Co-authorship network of co-authors of Mine Eray

This figure shows the co-authorship network connecting the top 25 collaborators of Mine Eray. A scholar is included among the top collaborators of Mine Eray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mine Eray. Mine Eray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Joensuu, Kristiina, et al.. (2023). Core needle biopsies alter the amounts of CCR5, Siglec-15, and PD-L1 positivities in breast carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(2). 215–224. 1 indexed citations
3.
Joensuu, Kristiina, et al.. (2023). Quantities of CD3+, CD8+ and CD56+ lymphocytes decline in breast cancer recurrences while CD4+ remain similar. Diagnostic Pathology. 18(1). 3–3. 3 indexed citations
4.
Eray, Mine, et al.. (2017). RIP1 has a role in CD40-mediated apoptosis in human follicular lymphoma cells. Immunobiology. 222(11). 998–1003. 3 indexed citations
5.
6.
Kuitunen, Hanne, Taina Turpeenniemi‐Hujanen, Sirpa Leppä, et al.. (2015). Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective study. Acta Oncologica. 54(6). 939–943. 15 indexed citations
7.
Ropponen, Antti, et al.. (2015). ERK1/2 has an essential role in B cell receptor- and CD40-induced signaling in an in vitro model of germinal center B cell selection. Molecular Immunology. 67(2). 240–247. 17 indexed citations
8.
Hartmann, Sylvia, Mine Eray, Claudia Döring, et al.. (2014). Diffuse large B cell lymphoma derived from nodular lymphocyte predominant Hodgkin lymphoma presents with variable histopathology. BMC Cancer. 14(1). 332–332. 18 indexed citations
9.
Ropponen, Antti, Mikko Mättö, Mine Eray, et al.. (2009). The involvement of mitochondria and the caspase-9 activation pathway in rituximab-induced apoptosis in FL cells. APOPTOSIS. 14(5). 687–698. 36 indexed citations
10.
Ropponen, Antti, et al.. (2009). Dexamethasone-induced apoptosis and up-regulation of Bim is dependent on glycogen synthase kinase-3. Leukemia Research. 33(12). 1714–1717. 22 indexed citations
11.
Ropponen, Antti, Mikko Mättö, Mine Eray, et al.. (2009). Feedback Regulation of Mitochondria by Caspase‐9 in the B Cell Receptor‐Mediated Apoptosis. Scandinavian Journal of Immunology. 70(6). 574–583. 11 indexed citations
12.
Ropponen, Antti, Mikko Mättö, Mine Eray, et al.. (2008). PDTC enables type I TRAIL signaling in type II follicular lymphoma cells. Leukemia Research. 33(6). 829–836. 11 indexed citations
13.
Mättö, Mikko, et al.. (2005). Inhibition of PI3-kinase–Akt pathway enhances dexamethasone-induced apoptosis in a human follicular lymphoma cell line. Experimental Cell Research. 312(3). 322–30. 35 indexed citations
14.
Skommer, Joanna, Donald Włodkowic, Mikko Mättö, Mine Eray, & Jukka Pelkonen. (2005). HA14-1, a small molecule Bcl-2 antagonist, induces apoptosis and modulates action of selected anticancer drugs in follicular lymphoma B cells. Leukemia Research. 30(3). 322–331. 210 indexed citations
15.
Eray, Mine, et al.. (2003). Follicular Lymphoma Cell Lines, an In Vitro Model for Antigenic Selection and Cytokine‐Mediated Growth Regulation of Germinal Centre B Cells. Scandinavian Journal of Immunology. 57(6). 545–555. 34 indexed citations
16.
Mättö, Mikko, et al.. (2003). Kinetics and signaling requirements of CD40‐mediated protection from B cell receptor‐induced apoptosis. European Journal of Immunology. 33(10). 2783–2791. 21 indexed citations
17.
Eray, Mine, et al.. (2001). Flow cytometric analysis of apoptotic subpopulations with a combination of Annexin V-FITC, propidium iodide, and SYTO 17. Cytometry. 43(2). 134–142. 88 indexed citations
18.
Eray, Mine, et al.. (1994). Cross-linking of surface IgG induces apoptosis in a bcl-2 expressing human follicular lymphoma line of mature B cell phenotype. International Immunology. 6(12). 1817–1827. 21 indexed citations
19.
Knuutila, Sakari, Juha Klefström, J. Szymańska, et al.. (1994). Two novel human B‐cell lymphoma lines of lymphatic follicle origin: Cytogenetic, molecular genetic and histopathological characterisation. European Journal Of Haematology. 52(2). 65–72. 21 indexed citations
20.
Kaartinen, Maija, et al.. (1994). Implanted Solid Human Tumours Grow Under the Renal Capsule of Cyclosporin‐Immunosuppressed Rats. Scandinavian Journal of Immunology. 39(6). 618–624. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masayuki Asano Breakdown of academic impact, for papers by Babette Aicher Breakdown of academic impact, for papers by Prahlad V. Raninga Breakdown of academic impact, for papers by Mikko Mättö Breakdown of academic impact, for papers by Shilpak Chatterjee Breakdown of academic impact, for papers by Roseanne S. Wexler Breakdown of academic impact, for papers by Isabel Serrano Breakdown of academic impact, for papers by Mohini Singh Breakdown of academic impact, for papers by Carla Vetrugno Breakdown of academic impact, for papers by Ahmed F. Salem
Rankless by CCL
2026